New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Nearly 2.2 million patients were prescribed a GLP-1 RA between January 2019 and December 2025, according to the study.

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Tirzepatide doesn’t necessarily wear off after 5 days. The half-life of tirzepatide is 5 days, meaning the amount you have in ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

There is so much talk about weight loss these days with drugs to make it easy — Ozempic, Wegovy, Zepbound — all claiming to ...

The Ozempic effect: How weight loss drugs are changing the menu at your favorite restaurant - Twelve percent of Americans ...

Patients who discontinue popular weight-loss medications like Ozempic and Wegovy typically regain the weight they lost within ...

Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...

Jan 8 (Reuters) - Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic ...

Retatrutide is an exciting GLP-1 drug that has explosive potential.

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...